The Prima photovoltaic retinal stimulation microchip, a brain-computer interface device designed to restore vision in patients with geographic atrophy, has launched commercially across 30 European countries.
July 24, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Science Corp's Prima retina implant restores some sight and has won EU approval, the first US brain-implant device to reach…
Audio version of Groundbreaking Retina Chip Designed to Restore Sight to Go on Sale in Europe
Science Corporation has secured EU regulatory approval for its innovative brain-computer interface, designed to restore vision…
Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.
Science Corp's PRIMA retinal implant gains EU approval, marking progress in neurotech market. Aims for $100M annual revenue to…
Science describes PRIMA as an "investigational" retinal implant designed to combat vision loss caused by GA and AMD. For the time…
Vision-restoring chip gains EU approval
